Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake

Abstract Previous studies have shown that pyruvate carboxylase (PC) plays a key role in the occurrence and progression of thyroid cancer (TC); however, the relationship between PC and iodine-refractory TC is unclear. Therefore, the present study aimed to investigate the molecular mechanism of PC in...

Full description

Bibliographic Details
Main Authors: Yang Liu, Chang Liu, Yu Pan, Jinxin Zhou, Huijun Ju, Yifan Zhang
Format: Article
Language:English
Published: Nature Publishing Group 2022-10-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-022-01214-y
_version_ 1828318387970768896
author Yang Liu
Chang Liu
Yu Pan
Jinxin Zhou
Huijun Ju
Yifan Zhang
author_facet Yang Liu
Chang Liu
Yu Pan
Jinxin Zhou
Huijun Ju
Yifan Zhang
author_sort Yang Liu
collection DOAJ
description Abstract Previous studies have shown that pyruvate carboxylase (PC) plays a key role in the occurrence and progression of thyroid cancer (TC); however, the relationship between PC and iodine-refractory TC is unclear. Therefore, the present study aimed to investigate the molecular mechanism of PC in the malignant progression and loss of iodine uptake in papillary TC (PTC) and to explore the potential therapeutic effect of PC inhibitors in iodine-refractory PTC. PC increased cell proliferation, invasion, and metastasis, inhibited expression of the iodine metabolism-related genes TSHR, NIS, TPO, and TG, and decreased the iodine-uptake capacity by activating the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway in PTC cell lines. Furthermore, the PC inhibitor ZY-444 effectively inhibited the activation of PC, reduced the malignant invasiveness, and restored the expression of iodine metabolism-related genes and the iodine-uptake capacity in PTC cells. These findings suggest that PC activation is involved in the progression of iodine-refractory TC and that PC inhibitors may represent a potentially novel targeted therapy for iodine-refractory TC.
first_indexed 2024-04-13T17:41:14Z
format Article
id doaj.art-2ed49eba997a482fa090e7052139fff3
institution Directory Open Access Journal
issn 2058-7716
language English
last_indexed 2024-04-13T17:41:14Z
publishDate 2022-10-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj.art-2ed49eba997a482fa090e7052139fff32022-12-22T02:37:10ZengNature Publishing GroupCell Death Discovery2058-77162022-10-018111310.1038/s41420-022-01214-yPyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptakeYang Liu0Chang Liu1Yu Pan2Jinxin Zhou3Huijun Ju4Yifan Zhang5Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, School of MedicineDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, School of MedicineDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, School of MedicineDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, School of MedicineDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, School of MedicineDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, School of MedicineAbstract Previous studies have shown that pyruvate carboxylase (PC) plays a key role in the occurrence and progression of thyroid cancer (TC); however, the relationship between PC and iodine-refractory TC is unclear. Therefore, the present study aimed to investigate the molecular mechanism of PC in the malignant progression and loss of iodine uptake in papillary TC (PTC) and to explore the potential therapeutic effect of PC inhibitors in iodine-refractory PTC. PC increased cell proliferation, invasion, and metastasis, inhibited expression of the iodine metabolism-related genes TSHR, NIS, TPO, and TG, and decreased the iodine-uptake capacity by activating the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway in PTC cell lines. Furthermore, the PC inhibitor ZY-444 effectively inhibited the activation of PC, reduced the malignant invasiveness, and restored the expression of iodine metabolism-related genes and the iodine-uptake capacity in PTC cells. These findings suggest that PC activation is involved in the progression of iodine-refractory TC and that PC inhibitors may represent a potentially novel targeted therapy for iodine-refractory TC.https://doi.org/10.1038/s41420-022-01214-y
spellingShingle Yang Liu
Chang Liu
Yu Pan
Jinxin Zhou
Huijun Ju
Yifan Zhang
Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake
Cell Death Discovery
title Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake
title_full Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake
title_fullStr Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake
title_full_unstemmed Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake
title_short Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake
title_sort pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake
url https://doi.org/10.1038/s41420-022-01214-y
work_keys_str_mv AT yangliu pyruvatecarboxylasepromotesmalignanttransformationofpapillarythyroidcarcinomaandreducesiodineuptake
AT changliu pyruvatecarboxylasepromotesmalignanttransformationofpapillarythyroidcarcinomaandreducesiodineuptake
AT yupan pyruvatecarboxylasepromotesmalignanttransformationofpapillarythyroidcarcinomaandreducesiodineuptake
AT jinxinzhou pyruvatecarboxylasepromotesmalignanttransformationofpapillarythyroidcarcinomaandreducesiodineuptake
AT huijunju pyruvatecarboxylasepromotesmalignanttransformationofpapillarythyroidcarcinomaandreducesiodineuptake
AT yifanzhang pyruvatecarboxylasepromotesmalignanttransformationofpapillarythyroidcarcinomaandreducesiodineuptake